Antibody procurement: How to choose between imported and domestic bioreagent companies when there are large differences in lead time and price?

For multi-antibody procurement, it is advisable not to bundle everything with one supplier; instead, split orders based on target criticality and application. For core targets used in both WB and IHC, especially modified antibodies and signaling pathway phospho-antibodies, prioritize imported brands like CST/Abcam. If lead times are unstable, ask for Shanghai in-stock SKUs, which can arrive in 3-5 days if available. For routine structural proteins or those with sufficient domestic validation in the literature, use Proteintech, ABclonal, Affinity, etc., mostly priced at 500-1000, with short lead times. In terms of channels, UniV, Dakewe, and Zenith often have stock; have them confirm warehouse and expiration date for each SKU individually, rather than just relying on product pages. Bundling saves effort, but since domestic channels and imported brands excel in different targets, buying separately is more practical.

Recent procurement experience shows that the main difference between imported and domestic lead times lies in the "Shanghai in-stock" item. Some commonly used catalog numbers from imported CST/Abcam have Shanghai stock, and orders placed on business days can arrive in 2-4 days; for items without stock, a quoted lead time of 2-5 weeks is normal, so before placing an order, always have the sales representative check real-time inventory. Domestic brands such as ABclonal, Affinity, and ZEN BIO have good coverage in Shanghai warehouses, many with next-day delivery, and prices are also more likely to fall within 500-1000. For your seven or eight antibodies, you can split them into two batches: first buy through domestic channels with short lead times to get the experiment running, while waiting for the core imported antibodies. It is not recommended to lock everything into one supplier. You can ask UNIV or Dakewe for a quote on the imported package, and then ask a domestic channel for a quote on the domestic package, comparing stock availability rate, shelf life, and whether returns or exchanges are allowed. For key targets, still reserve budget for imported antibodies; for routine targets, domestic antibodies are usually sufficient.

The differences between imported and domestic products should be verified yourself before deciding. With a budget of 500-1500 for seven or eight primary antibodies, going fully imported will be tight. It is recommended to first select 2-4 core targets and use CST/Abcam for those, while using domestic brands for the rest. For domestic channels, on the first purchase you can request small packaging or trial samples, and use existing positive/negative samples for WB and IHC pilot experiments: for WB, check band specificity, background, and whether the molecular weight matches the target protein; for IHC, check localization, background, and negative controls. Regarding lot-to-lot stability, record the lot number, request the CoA, try to buy the same lot for the same target, and after key antibodies arrive, first run a parallel comparison with the old antibodies. Recombinant antibodies or IHC-validated antibodies from Proteintech, ABclonal, and HuaAn Biotechnology are more reliable, but they do not cover all targets.